Chemotargets Clarity Vista Panel Detection Scanner
This scanner detects the use of Chemotargets Clarity Vista login panels on digital assets. It is valuable for identifying potential security misconfigurations on your systems.
Short Info
Level
Medium
Single Scan
Single Scan
Can be used by
Asset Owner
Estimated Time
10 seconds
Time Interval
26 days 8 hours
Scan only one
URL
Toolbox
-
Chemotargets Clarity Vista is widely used by pharmaceutical companies for pharmacovigilance, drug safety, and risk assessment purposes. It acts as an integrative platform to help industry professionals in identifying and managing risks associated with chemical compounds. The software supports health authorities, research institutions, and regulatory agencies in monitoring drug safety and increasing the efficiency of pharmacovigilance activities. It is also deployed by pharmaceutical researchers who are involved in drug development and safety assessments. The software's versatility makes it an essential tool for managing large datasets and improving decision-making processes in drug safety, supporting both internal company objectives and regulatory compliance requirements.
The vulnerability detected here relates to the identification of login panels, which can reveal the presence of software that may be improperly secured. Detecting a login panel could indicate that the default configuration is potentially exposed, allowing unauthorized users to discover the surface of the application. Such detections are significant as they might hint at incomplete protective measures around sensitive application interfaces. With this detection, vulnerabilities related to authentication and authorization mechanisms can be further investigated to prevent unauthorized access. Therefore, identifying panels and exposing unnecessary access points becomes crucial in maintaining robust security practices in complex software environments.
The scanner identifies potential vulnerabilities by examining the HTTP response codes and specific title tags or keywords present on suspected login pages. The combination of status codes and content keywords helps confirm the existence of the login panel. Technical details such as the response code 200 and keyword "clarityvista" or phrases like "clarity pharmacovigilance" in the body indicate successful detection. These parameters provide a consistent method to validate whether the login page for Chemotargets Clarity Vista has been exposed.
Exposing a login panel can lead to varied and potentially severe impacts. Unauthorized users may attempt brute-force attacks to gain access, potentially resulting in a compromised system and unauthorized data manipulation. If login panels are exploited, they may lead to data breaches, unauthorized access to sensitive data, and potential violations of privacy laws. Misconfigured access points often become attractive targets for attackers aiming to exploit authentication weaknesses. Therefore, unrestricted access to a login panel is a security risk that requires careful management and swift remedial action.
REFERENCES